Biotech Values

[mouton29]

<<Then, two weeks ago, Teva disclosed that it had received an FDA Warning Letter regarding contamination issues at its Jerusalem oral solid dosage plant. While this plant is not involved in manufacturing generic Lovenox, the Agency wrote, “Until all corrections have been completed and FDA has confirmed corrections of the violations and your firm’s compliance with [Current Good Manufacturing Practice regulations], FDA may withhold approval of any new applications or supplements listing your firm as a drug product manufacturer.”>>

So by that logic, sometime shortly after problems at the Jerusalem ORAL plant are fixed, all outstanding TEVA applications and supplements on all drugs - whether related to that plant or not -- will be approved. How many applications is that, and wouldn't it make TEVA the buy of the century (or perhaps, human history)?